Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2019 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
September 16, 2019 08:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award

MELVILLE, N.Y., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that a...
September 13, 2019 20:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Comments on Recent Promotional Activity

MELVILLE, N.Y., Sept. 13, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell - based therapies, is providing comment on...
September 11, 2019 08:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

MELVILLE, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
September 05, 2019 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements

MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at...
July 31, 2019 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor

MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
April 29, 2019 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders

MELVILLE, N.Y., April 29, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
February 27, 2019 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces the Creation of a Disc Advisory Committee

MELVILLE, N.Y., Feb. 27, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
November 15, 2018 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States

MELVILLE, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
October 18, 2018 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer

MELVILLE, N.Y., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...